Taken together, these results reveal the importance of an intact G1/S transition for palbociclib response and provide a rationale for utilizing Rb in combination with LMWE as biomarkers of response to the combination of CDK4/6, aromatase and autophagy inhibitors in ER+ breast cancer. This evidence concerns the gene CDK4 and breast carcinoma.